CIK 0001628908
- Large accelerated filer
Evolent Health, Inc.
Sign in to watch- Ticker
- EVH
- Exchange
- NYSE
- Industry
- Services-Management Services
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 320454912
- Phone
- +1 571-389-6000
- Business address
- 1812 NORTH MOORE ST, SUITE 1705, ARLINGTON, VA, 22209
- 4 Grant or award Director acquired 4,570 shares (grant or award)
- 4 Grant or award Director acquired 4,570 shares (grant or award)
- 4 Grant or award Director acquired 4,570 shares (grant or award)
- 4 Grant or award Director acquired 4,570 shares (grant or award)
- 4 Grant or award Director acquired 4,570 shares (grant or award)
- 4 Grant or award Director acquired 4,570 shares (grant or award)
- 4 Grant or award Director acquired 4,570 shares (grant or award)
- 4 Open-market sale Director sold 4,000 shares at $25.75 ($103,000)
- 4 Open-market sale CEO, Valence Health sold 959 shares at $25.75 ($24,694)
- 4 Open-market sale Chief Financial Officer sold 10,495 shares at an average $26.95 ($282,846)
- 4 Open-market sale Principal Accounting Officer sold 4,795 shares at an average $22.92 ($109,903)
- 4 Open-market sale CEO, Valence Health sold 6,000 shares at an average $24.13 ($144,800)
- 4 Open-market sale Chief Executive Officer sold 16,300 shares at an average $24.12 ($393,153)
- 4 Open-market sale President sold 15,000 shares at $22.86 ($342,900)
- 4 Open-market sale CEO, Valence Health sold 13,640 shares at $24.30 ($331,452)
- 4 Open-market sale Chief Operating Officer sold 57,433 shares at $24.30 ($1,395,622)
- 4 Open-market sale President sold 114,865 shares at $24.30 ($2,791,220)
- 4 Open-market sale Chief Executive Officer sold 114,865 shares at $24.30 ($2,791,220)
- 4 Open-market sale Chief Financial Officer sold 47,508 shares at $24.30 ($1,154,444)
- 4 Open-market sale General Counsel sold 17,230 shares at $24.30 ($418,689)
Page 16 of 22 · 421 filings